Merck KGaA (XTER:MRK)
€ 141.85 0.25 (0.18%) Market Cap: 61.67 Bil Enterprise Value: 69.21 Bil PE Ratio: 23.06 PB Ratio: 2.19 GF Score: 85/100

Q1 2021 Merck KGaA Earnings Call Transcript

May 12, 2021 / 12:00PM GMT
Release Date Price: €135.75 (-2.27%)
Operator

Good day, and welcome to the Merck Quarter 1, 2021 Analyst Telco Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Constantin Fest. Please go ahead.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Dear ladies and gentlemen, a very warm welcome from my side. My name is Constantin Fest. I'm here the Head of Investor Relations at Merck. And I am delighted to have with me here today for the presentation, but also for the Q&A, Belen Garijo, CEO of the Merck Group; as well as Marcus Kuhnert, CFO of the group.

For the Q&A part of this call, Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics, will also join to answer your questions on Healthcare and Electronics. Matthias Heinzel, our new CEO of Life Science will join this call for a brief introduction while Andrew Bulpin, In Charge of Life Science Process Solutions, will be available for your detailed questions on Life Science and Process Solutions in particular.

Two more things,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot